CNTB
Connect Biopharma Holdings
CNTB
CNTB
15 hedge funds and large institutions have $8.4M invested in Connect Biopharma Holdings in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.43M | |
| 2 | +$237K | |
| 3 | +$18.3K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$14.5K |
| 5 |
KMWM
Keudell/Morrison Wealth Management
Salem,
Oregon
|
+$13.2K |
Top Sellers
| 1 | -$4.64M | |
| 2 | -$532K | |
| 3 | -$434K | |
| 4 |
BlackRock
New York
|
-$101K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$50.4K |